26 results
PRE 14A
ABSI
Absci Corp
11 Apr 23
Preliminary proxy
5:49pm
matters to serve on the audit committee. Our board of directors has designated Ms. McGinnis as an “audit committee financial expert,” as defined under
8-K
EX-99.1
ABSI
Absci Corp
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
.
Deepened Scientific Advisory Board with addition of in silico antibody design expert Dr. Victor Greiff, synthetic biology pioneer Dr. Timothy Lu
8-K
EX-3.1
ia9 pfwvx6udjahp6a8s
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEF 14A
uipxz8u45wwcl6g8ocfz
26 Apr 22
Definitive proxy
4:39pm
8-K
EX-3.2
e1qterbxm6
26 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
ctonabdovar
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
tb98ny3e z7
8 Jul 21
IPO registration (amended)
5:04pm
S-1
EX-10.11
84t4a9jd
30 Jun 21
IPO registration
3:20pm
S-1
q6ol9 8sgzd672c5ors
30 Jun 21
IPO registration
3:20pm
S-1
EX-3.3
sihlnq v21anju
30 Jun 21
IPO registration
3:20pm
S-1
EX-10.12
l63txi
30 Jun 21
IPO registration
3:20pm
S-1
EX-10.1
phw6p
30 Jun 21
IPO registration
3:20pm